By studying how different pluripotent stem cell lines build muscle, researchers have for the first time discovered how epigenetic mechanisms can be triggered to accelerate muscle cell growth, providing new insights for developing therapies for muscle disease, injury and atrophy.
Intravenous injection of bone marrow derived stem cells (MSCs) in patients with spinal cord injuries led to significant improvement in motor functions, researchers report.
Source: Neurology Today
Autologous non-myeloablative hematopoietic stem cell transplantation (HSCT) was safe and effective in a subset of patients with stiff person spectrum disorder (SPSD), according to a small open-label study, published in the December 14 online edition of Neurology.
Source: Natural Products Insider
Joint pain brought on by repetitive motion compression, in the form of osteoarthritis, and the auto-immune related rheumatoid arthritis, afflict millions. Studies indicate Terminalia chebula, collagen, curcumin and vitamin D show helpful promise, while glucosamine supplementation for osteoarthritis has yielded improved mobility and relief of pain.
Source: EIN News
Chronic conditions, such as degenerative arthritis, can often be managed with intermittent injections. Depending on the condition and underlying pathology, many patients can maintain a pain-free lifestyle for several years by only receiving injections every three to four months.
Pioneering new research has made a pivotal breakthrough that dispel concerns that human stem cells could contain cancer-causing mutations.
The first patient has enrolled in a Phase II clinical trial evaluating a stem cell therapy for the potential early treatment of traumatic injuries and their subsequent complications at The University of Texas Health Science Center at Houston (UTHealth).